×

A free KDIGO virtual event covering ANCA-Associated Vasculitis, Complement-Mediated Kidney Disease, IgA Nephropathy, and Lupus Nephritis–available in multiple time zones!

Overview

KDIGO GEMs (Guideline Education Meetings) is a new program offering virtual education on the latest KDIGO Guidelines and evidence-based updates. These interactive events are designed to empower healthcare professionals with the knowledge and tools needed to understand and apply KDIGO recommendations in real-world clinical practice. By combining cutting-edge guidance with practical insights, KDIGO GEMs provide an engaging platform to enhance clinician expertise, improve patient outcomes, and advance global best practices in kidney disease care.

 

KDIGO will launch the first-ever GEMs with a focus on glomerular diseases, including topics such as Lupus NephritisANCA-associated Vasculitis, IgA Nephropathy, and Complement-Mediated Kidney Disease. This innovative program will provide a comprehensive understanding of how to apply KDIGO’s evidence-based recommendations and practice points most effectively. Through engaging case-based illustrations, participants will gain practical tools and insights to elevate patient care and optimize outcomes in glomerular disease management.

 

The presentations will feature live Q&A sessions for each topic module where the audience can interact with key opinion leaders about the latest state-of-the-art, challenging clinical scenarios and optimal management approaches for complex patients. Click to learn more and register.

Learning Objectives

  • Review the latest KDIGO guidance spanning the recent KDIGO GD updates on lupus nephritis, AAV, and IgA nephropathy, including deliberations from the recent 2022 Complement-Mediated Kidney Disease Controversies Conference
  • Understand the central takeaways from the KDIGO guideline updates and new developments and key differences from the prior 2021 guideline edition
  • Demonstrate the proper interpretation and application of KDIGO guidance via the use of case-based discussions
  • Address the management of challenging or controversial clinical scenarios
  • Understand the potential and limitations of newer drug combinations
  • Review ongoing studies and new therapeutic agents currently under investigation
  • Identify current gaps in knowledge, standing controversies, and near-term research agenda

Target Audience

  • Nephrologists (including trainees and fellows)
  • Primary Care Physicians
  • Nurses and Allied Health Professionals
KDIGO would like to thank the following partners: Amgen, Calliditas, CSL Vifor, GSK, Novartis, Otsuka, Travere Therapeutics, and Vera Therapeutics.  

 

 


Resources